MedTrace Logo

Study on Effectiveness and Safety of LBBaP With Solia S and Selectra 3D Developed by BIOTRONIK

NCT05793502 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-08-26

No results posted yet for this study

Summary

This study is aimed to assess the effectiveness and safety of LBBaP with Solia S and Selectra 3D in the Chinese population by analyzing the operation success rate and the system stability during follow-up visits.

Conditions

  • Consented to Participate in the Trial and Signed an ICF
  • Patients With an Indication for PM Implantation or CRTP

Interventions

DEVICE

Solia S and Selectra 3D Developed by BIOTRONIK

LBBaP with Solia S and Selectra 3D Developed by BIOTRONIK

Sponsors & Collaborators

  • Chinese Academy of Medical Sciences, Fuwai Hospital

    lead OTHER

Principal Investigators

  • Chen Keping, Doctor · Fu Wai Hospital, Chinese Academy of Medical Sciences, Fu Wai, China

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-04
Primary Completion
2025-04-20
Completion
2025-04-20
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05793502 on ClinicalTrials.gov